International Journal of Cardiology
Volume 76, Issue 2 , Pages 117-122 , November 2000

Leptin serum levels in cachectic heart failure patients: Relationship with tumor necrosis factor-α system

  • Gerasimos S Filippatos, MD

      Affiliations

    • First Department of Cardiology, Evangelismos Hospital, Athens, Greece
    • Corresponding Author InformationCorresponding author. Ambelokipi, 28 Doukissis Plakentias Street, 11523 Athens, Greece. Tel.: +30-1-6745-222; fax: 30-1-7218-025
    • ,
  • Karmelos Tsilias, MD

      Affiliations

    • First Department of Cardiology, Evangelismos Hospital, Athens, Greece
    • ,
  • Koula Venetsanou, BSc

      Affiliations

    • Athens University School of Nursing ICU, Kifisia, Athens, Greece
    • ,
  • Elias Karambinos, MD

      Affiliations

    • First Department of Cardiology, Evangelismos Hospital, Athens, Greece
    • ,
  • Dimitris Manolatos, MD

      Affiliations

    • Second Department of Cardiology, Evangelismos Hospital, Athens, Greece
    • ,
  • Athanasios Kranidis, MD

      Affiliations

    • First Department of Cardiology, Evangelismos Hospital, Athens, Greece
    • ,
  • John Antonellis, MD

      Affiliations

    • Department of Invasive Cardiology, Evangelismos Hospital, Athens, Greece
    • ,
  • Fotis Kardaras, MD

      Affiliations

    • Second Department of Cardiology, Evangelismos Hospital, Athens, Greece
    • ,
  • Lambros Anthopoulos, MD

      Affiliations

    • First Department of Cardiology, Evangelismos Hospital, Athens, Greece
    • ,
  • George Baltopoulos, MD

      Affiliations

    • Athens University School of Nursing ICU, Kifisia, Athens, Greece

Received 16 September 1999 ,Revised 18 May 2000 ,Accepted 13 June 2000.

References 

  1. Anker SD, Ponikowski P, Varney S, et al.  Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050–1053
  2. Zhao SP, Zeng LH. Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia. Int. J. Cardiol. 1997;58:257–261
  3. Anker SD, Clark Al, Kemp M, et al.  Tumor necrosis factor and steroid metabolism in chronic heart failure. Possible relation to muscle wasting. J. Am. Coll. Cardiol. 1997;30:997–1001
  4. Cederholm T, Wretlind B, Hellstrom K, et al.  Enhanced generation of interleukins 1-beta and 6 may contribute to the cachexia of chronic disease. Am. J. Clin. Nutr. 1997;65:876–882
  5. Okuyama M, Yamaguchi S, Nazaki N, Yamaoka M, Shirakabe M, Tomoike H. Serum levels of soluble form of Fas molecule in patients with congestive heart failure. Am. J. Cardiol. 1997;79:1698–1701
  6. Nishigaki K, Minatoguchi S, Seishima M, et al.  Plasma Fas ligand, an inducer of apoptosis and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J. Am. Coll. Cardiol. 1997;29:1214–1220
  7. Filippatos G, Leche C, Sunga R, et al.  Expression of FAS adjacent to fibrotic foci in the failing human heart is not associated with increased apoptosis. Am. J. Physiol. 1999;277:H445–H451
  8. Zumbach MS, Boehme MWJ, Wahl P, Stremmel W, Ziegler R, Nawroth PP. Tumor necrosis factor increases serum leptin levels in humans. J. Clin. Endocrinol. Metab. 1997;82:4080–4082
  9. Mantzoros CS, Moschos S, Avramopoulos I, et al.  Leptin concentrations in relation to body mass index and the tumor necrosis factor – a system in humans. J. Clin. Endocrinol. Metab. 1997;82:3408–3413
  10. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse ob gene and its human homologue. Nature. 1994;372:425–432
  11. Hallaas JL, Gajinala KS, Maffei M, et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269:543–546
  12. Leyva F, Anker SD, Egeter K, Stevenson JC, Coats AJS. Hyperleptinaemia in chronic heart failure: relationships with insulin. Eur. Heart J. 1998;19:1547–1551
  13. Ferrari R. The importance of cachexia in the syndrome of heart failure. Eur. Heart J. 1997;18:187–189
  14. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of TNF in congestive heart failure. N. Engl. J. Med. 1990;323:236–241
  15. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor mediated regional sympathetic nerve activation by leptin. J. Clin. Invest. 1997;100:270–278
  16. Lonnqvist F, Arner P, Nordfors L, et al.  Overexpression of the obese (OB) gene in adipose tissue of human obese subjects. Nature Med. 1995;1:950–953
  17. Maffei M, Halaas J, Ravussin E, et al.  Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight reduced subjects. Nature Med. 1995;1:1155–1161
  18. Considine RV, Sinha MK, Heiman ML, et al.  Serum immunoreactive leptin concentrations in normal weight and obese humans. N. Engl. J. Med. 1996;334:292–295
  19. Sinha MK, Caro JF. Clinical aspects of leptin. Vitam. Horm. 1998;54:1–30
  20. Loffreda S, Yang SQ, Lin HZ, et al.  Leptin regulates proinflammatory immune responses. FASEB J. 1998;12(1):57–65
  21. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998;394:897–901
  22. Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, et al. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am. J. Physiol. 1999;276(1):R136–R142Part 2
  23. Toth MJ, Gottlieb SS, Fisher ML, Ryan AS, Nicklas BJ, Poehlman ET. Plasma leptin concentrations and energy expenditure in heart failure patients. Metabolism. 1997;46:450–453
  24. Murdoch DR, Rooney E, Dargie HJ, Shapiro D, Morton JJ, McMurray JJV. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure. Heart. 1999;82:352–356
  25. Anker SD, Ponikowski PP, Clark AL, et al.  Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur. Heart J. 1999;20:683–693
  26. Simmons JP, Schols AM, Campfield LA, Wouters EF, Saris WH. Plasma concentration of total leptin and human lung cancer associated cachexia. Clin. Sci. (Colch.). 1997;93:273–277
  27. Barbier M, Cherbut C, Aube AC, Blottiere HM, Galmiche JP. Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut. 1998;43:783–790
  28. Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJ. Elevated CD14 receptors and altered cytokines in chronic heart failure. Am. J. Cardiol. 1997;79:1426–1430
  29. Niebauer J, Volk HD, Kemp M, et al.  Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 1999;353:1838–1842
  30. Mantzoros CS, Prasad AS, Beck FW, et al.  Zinc may regulate serum leptin concentrations in humans. J. Am. Coll. Nutr. 1998;17:270–275
  31. Takahashi N, Waelput W, Guisez Y. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J. Exp. Med. 1999;189:207–212
  32. Ranganathan S, Maffei M, Kern PA. Adipose tissue ob mRNA expression in humans: discordance with plasma leptin and relationship with adipose TNF alpha expression. J. Lipid. Res. 1998;39:724–730
  33. Cleland JGF, Clark AL. Leptin and cardiac cachexia: marker or mediator?. Eur. Heart J. 1998;19:421–422
  34. Sinha MK, Opentanova I, Ohannesian JP, et al.  Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short term fasting. J. Clin. Invest. 1996;98(6):1277–1282
  35. Filippatos G, Tsilias K, Baltopoulos G, Anthopoulos L. Serum leptin concentration in heart failure patients: does the literature reflect reality?. Eur. Heart J. 2000;21(4):334

PII: S0167-5273(00)00397-1

International Journal of Cardiology
Volume 76, Issue 2 , Pages 117-122 , November 2000

Article Tools

* Image Usage & Resolution